Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluating the use of Liraglutide in patients with Type 1 Diabetes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaleida Health; University at Buffalo
• Collaborator: University at Buffalo
• Treatments: Liraglutide

Criteria

Inclusion Criteria:

• Type 1 Diabetes Mellitus

Exclusion Criteria:

• Type 2 Diabetes Mellitus